CD8A and neoplasm: Importantly, SMU‐Z1 functions by promoting splenic proliferation, especially by up‐regulating the CD8+ cytotoxic T lymphocytes, NK cells and DC cells, which in turn contribute to significant anti‐tumor response against FBL3 leukemia in vivo.